跳至主要内容
临床试验/NCT02143362
NCT02143362Unknown4 期

Dexmedetomidine Combined With the Closed Loop of Target Controlled Infusion of Propofol for Anesthesia With Intraoperative Wake Up-single Center,Random,Controlled Trial

Second Affiliated Hospital of Xi'an Jiaotong University0 个研究点目标入组 60 人开始时间: 2014年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
60
主要终点
Blood sugar concentration

研究概览

简要总结

The study designed to explore the efficacy and safety of the closed loop of target controlled infusion dexmedetomidine combined with propofol for anesthesia with intraoperative wake up.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Written informed consent.
  • Ongoing brain functional area surgery with intraoperative wake up.
  • American Society of Anesthesiologists class I to II.
  • Aged between 18 and 65 years old.
  • Weight between plus or minus 20% of the standard weight. Male: (height cm - 80) × 70% = standard weight Female: (height cm - 70) × 60% = standard weight

排除标准

  • History of hypertension.
  • Serious heart,brain,liver,kidney, pulmonary, and endocrine disease or serious infection.
  • Mental disability or mental disease.
  • Use of sedative drug.
  • Suspected or confirmed long term use of narcotic analgesics.
  • Inability to exchange.
  • Suspected or confirmed difficult airway.
  • Suspected of malignant hyperthermia.
  • Neuromuscular disease.
  • Allergic to investigational products or with other contraindication.
  • Subjects who are breastfeeding or pregnant.
  • Participated in other study within 30 days .

研究组 & 干预措施

Dexmedetomidine group

Experimental
  1. Infusion of dexmedetomidine(0.8μg/kg) at10 minutes before anesthesia induction.
  2. Infusion of dexmedetomidine at 0.4 μg•kg-1•h-1during anesthesia maintenance.
  3. The infusion rate of dexmedetomidine was reduced to 0.1 μg•kg-1•h-1 for awaken test.

干预措施: Anesthesia induction,propofol, remifentanil ,cisatracurium (Drug)

Dexmedetomidine group

Experimental
  1. Infusion of dexmedetomidine(0.8μg/kg) at10 minutes before anesthesia induction.
  2. Infusion of dexmedetomidine at 0.4 μg•kg-1•h-1during anesthesia maintenance.
  3. The infusion rate of dexmedetomidine was reduced to 0.1 μg•kg-1•h-1 for awaken test.

干预措施: Anesthesia maintenance , propofol,remifentanil,cisatracurium (Drug)

Dexmedetomidine group

Experimental
  1. Infusion of dexmedetomidine(0.8μg/kg) at10 minutes before anesthesia induction.
  2. Infusion of dexmedetomidine at 0.4 μg•kg-1•h-1during anesthesia maintenance.
  3. The infusion rate of dexmedetomidine was reduced to 0.1 μg•kg-1•h-1 for awaken test.

干预措施: Awaken test (Procedure)

Control group

Placebo Comparator
  1. Infusion normal saline(0.8μg/kg) at 10 minutes before anesthesia induction.
  2. Infusion normal saline at 0.4 μg•kg-1•h-1 during anesthesia maintenance.
  3. The infusion rate of normal saline was reduced to 0.1 μg•kg-1•h-1 for awaken test.

干预措施: Anesthesia induction,propofol, remifentanil ,cisatracurium (Drug)

Control group

Placebo Comparator
  1. Infusion normal saline(0.8μg/kg) at 10 minutes before anesthesia induction.
  2. Infusion normal saline at 0.4 μg•kg-1•h-1 during anesthesia maintenance.
  3. The infusion rate of normal saline was reduced to 0.1 μg•kg-1•h-1 for awaken test.

干预措施: Anesthesia maintenance , propofol,remifentanil,cisatracurium (Drug)

Control group

Placebo Comparator
  1. Infusion normal saline(0.8μg/kg) at 10 minutes before anesthesia induction.
  2. Infusion normal saline at 0.4 μg•kg-1•h-1 during anesthesia maintenance.
  3. The infusion rate of normal saline was reduced to 0.1 μg•kg-1•h-1 for awaken test.

干预措施: Awaken test (Procedure)

结局指标

主要结局

Blood sugar concentration

时间窗: 30 minutes prior to awaken test,the moment of awake,5 minutes after awake,the moment after finish awaken test,10minutes after finish awaken test

Cortisol concentration

时间窗: 30 minutes prior to awaken test,the moment of awake,5 minutes after awake,the moment after finish awaken test,10minutes after finish awaken test

Success rate of awaken test

时间窗: The whole time of surgery,about 8 hours

The time from starting to awaken test to patient wakes up

时间窗: From starting to awaken test to patient wakes up,about 3 hours

Epinephrine concentration

时间窗: 30 minutes prior to awaken test,the moment of awake,5 minutes after awake,the moment after finish awaken test,10minutes after finish awaken test

Norepinephrine concentration

时间窗: 30 minutes prior to awaken test,the moment of awake,5 minutes after awake,the moment 30 minutes prior to awaken test,the moment of awake,5 minutes after awake,the moment after finish awaken test,10minutes after finish awaken test

次要结局

  • The duration of anesthesia from baseline to patient wake up(From baseline to patient wake up ,about 3 hours)
  • Heart rate(30 minutes prior to awaken test,the moment of awake,5 minutes after awake,the moment after finish awaken test,10minutes after finish awaken test)
  • The dosage of Cisatracurium before patient wakes up(From starting to awaken test to patient wakes up,about 3 hours)
  • Mean arterial pressure(30 minutes prior to awaken test,the moment of awake,5 minutes after awake,the moment after finish awaken test,10minutes after finish awaken test)
  • The dosage of remifentanil before patient wakes up(From starting to awaken test to patient wakes up,about 3 hours)
  • The dosage of propofol before patient wakes up(From starting to awaken test to patient wakes up,about 3 hours)
  • Bispectral electroencephalogram index(30 minutes prior to awaken test,the moment of awake,5 minutes after awake,the moment after finish awaken test,10minutes after finish awaken test)

研究者

发起方
Second Affiliated Hospital of Xi'an Jiaotong University
申办方类型
Other
责任方
Sponsor

相似试验